Rift-lines within European regulatory framework for biosimilars when taking heterogeneity and variation during lifecycle of the reference biologic and the biosimilar into account / / Malik Osmane.
Saved in:
VerfasserIn: | |
---|---|
Place / Publishing House: | Hamburg, Germany : : Anchor Academic Publishing,, 2014. 2014 |
Year of Publication: | 2014 |
Language: | English |
Online Access: | |
Physical Description: | 1 online resource (283 pages) :; illustrations (some color) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Advances in collating and using trial data / / Sylvie Chevret, Matthieu Resche-Rigon, editors.
Published: (2014.) -
Applications of high-resolution mass spectrometry in drug discovery and development / / editor, Lekha Sleno.
Published: (2014.) -
Eliminating bottlenecks for efficient bioanalysis / / editors, Wilson Z. Shou, Naidong Weng.
Published: (2014.) -
Microwaves in drug discovery and development : : recent advances / / editors, John Spencer, Mark Bagley.
Published: (2014.) -
WHO drug information. / Vol. 28 No. 3 2014. / / by World Health Organization.
Published: ([2014])